Dry Eye Syndromes Clinical Trials

12 recruiting

Dry Eye Syndromes Trials at a Glance

12 actively recruiting trials for dry eye syndromes are listed on ClinicalTrialsFinder across 6 cities in 10 countries. The largest study group is Not Applicable with 7 trials, with the heaviest enrollment activity in Birmingham, Cagliari, and Catanzaro. Lead sponsors running dry eye syndromes studies include Aston University, Centre Hospitalier Universitaire de Nice, and AJU Pharm Co., Ltd..

Browse dry eye syndromes trials by phase

Treatments under study

About Dry Eye Syndromes Clinical Trials

Looking for clinical trials for Dry Eye Syndromes? There are currently 12 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Dry Eye Syndromes trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Dry Eye Syndromes clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 112 of 12 trials

Recruiting
Not Applicable

Therapeutic Efficacy and Safety of Non-Invasive RF Treatment in Refractory MGD

Dry Eye Syndromes
The University of Hong Kong112 enrolled2 locationsNCT06220474
Recruiting
Not Applicable

Clinical Investigation Between the Topical Administration of a Tear Substitute With Ancillary Medicinal Substance and Hyaluronic Acid 0.3% (FBV_01) vs Hyaluronic Acid 0.3% in Subjects in the Treatment From Moderate to Severe DED

Dry Eye Disease (DED)Dry Eye Syndromes
FB Vision S.p.A74 enrolled2 locationsNCT07412860
Recruiting
Not Applicable

Protecting the Eyes of Gamers With Lubricating Eyedrops

Dry Eye Syndromes
Aston University28 enrolled1 locationNCT06163989
Recruiting
Not Applicable

Photobiomodulation With REd vs BluE Light (REBEL)

Dry Eye Syndromes
Aston University36 enrolled2 locationsNCT06371300
Recruiting

Three-dimensional Analysis of EMMPRIN on Conjunctival Epithelial Cells Surface in Severe Dry Eye Syndrome (ALTESSE)

Dry Eye SyndromesConjunctival Diseases
Fondation Ophtalmologique Adolphe de Rothschild100 enrolled1 locationNCT03358979
Recruiting
Not Applicable

Clinical Applications of Advanced Ophthalmic Imaging

DementiaMultiple SclerosisMyopia+3 more
University of Miami5,000 enrolled1 locationNCT03135327
Recruiting

Assessment of TFT by OCT in Healthy Subjects and Subjects With DES

Dry Eye Syndromes
Medical University of Vienna340 enrolled1 locationNCT02585414
Recruiting
Phase 1

Limbal Stem Cell Derived Exosome (LSC-Exo) Eye Drop for Treatment of Dry Eye

Dry Eye Syndromes
Iran University of Medical Sciences30 enrolled1 locationNCT06543667
Recruiting
Not Applicable

Efficacy of Platelet-Rich Plasma Injection in Dry Eye Syndrome

Dry Eye SyndromesSevere Dry Eye Syndromes
Centre Hospitalier Universitaire de Nice20 enrolled1 locationNCT06831253
Recruiting
Not Applicable

Difference of Tear Ferning Between Women with and Without Menopausal.

Dry Eye Syndromes
Chung Shan Medical University90 enrolled1 locationNCT06848829
Recruiting

Salivary Conductivity Screening for Dry Eye Disease and Sjögren's Syndrome

Sjogren's SyndromeDry Eye Syndromes
Chang Gung Memorial Hospital200 enrolled1 locationNCT06406933
Recruiting
Phase 3

Efficacy and Safety of AJU-S56 5% in Dry Eye Syndrome Patients

Dry Eye Syndromes
AJU Pharm Co., Ltd.396 enrolled1 locationNCT06291194